Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Development Of Immunosuppressant Drugs
3.2. Market Definition
3.3. Key Drivers
3.3.1. Increase In The Number Of Autoimmune Disorders
3.3.2. Rise In Organ Transplantation
3.3.3. Growth In The Pharmaceutical Industry
3.4. Key Restraints
3.4.1. Side Effects Of Immunosuppressant Drugs
3.4.2. Lack Of Awareness About Organ Donation

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape

5. Market By Distribution Channel
5.1. Hospital Pharmacies
5.2. Retail Pharmacies
5.3. Online Pharmacies

6. Market By End-User
6.1. Organ Transplantation
6.2. Autoimmune Disorders
6.3. Others

7. Market By Drug Class
7.1. Corticosteroids
7.2. Monoclonal Antibodies
7.3. Calcineurin Inhibitors
7.4. Mtor Inhibitors
7.5. Others

8. Geographical Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada

9. Company Profiles
9.1. Abbvie Inc
9.2. Allergan Plc (Acquired By Abvie Inc)
9.3. Astellas Pharma Inc
9.4. Bristol-Myers Squibb Company
9.5. Cipla Ltd
9.6. Dr. Reddy’S Laboratories Ltd
9.7. F Hoffmann-La Roche Ag
9.8. Glaxosmithkline Plc
9.9. Intas Pharmaceuticals Ltd (Accord Healthcare Ltd)
9.10. Janssen Pharmaceuticals Nv (Jhonson & Jhonson)
9.11. Mylan Nv
9.12. Novartis International Ag (Sandoz)
9.13. Pfizer Inc
9.14. Sanofi Sa
9.15. Veloxis Pharmaceuticals



List of Figures


Figure 1: Development Of Immunosuppressant Drugs
Figure 2: Key Investment Insights
Figure 3: Porter’S Five Force Analysis
Figure 4: Opportunity Matrix
Figure 5: Vendor Landscape
Figure 6: North America Immunosuppressant Drugs Market, Growth Potential, By Distribution Channel, In 2019
Figure 7: North America Immunosuppressant Drugs Market, By Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 8: North America Immunosuppressant Drugs Market, By Retail Pharmacies, 2019-2028 (In $ Million)
Figure 9: North America Immunosuppressant Drugs Market, By Online Pharmacies, 2019-2028 (In $ Million)
Figure 10: North America Immunosuppressant Drugs Market, Growth Potential, By End-User, In 2019
Figure 11: North America Immunosuppressant Drugs Market, By Organ Transplantation, 2019-2028 (In $ Million)
Figure 12: North America Immunosuppressant Drugs Market, By Autoimmune Disorders, 2019-2028 (In $ Million)
Figure 13: North America Immunosuppressant Drugs Market, By Others, 2019-2028 (In $ Million)
Figure 14: North America Immunosuppressant Drugs Market, Growth Potential, By Class, In 2019
Figure 15: North America Immunosuppressant Drugs Market, By Corticosteroids, 2019-2028 (In $ Million)
Figure 16: North America Immunosuppressant Drugs Market, By Monoclonal Antibodies, 2019-2028 (In $ Million)
Figure 17: North America Immunosuppressant Drugs Market, By Calcineurin Inhibitors, 2019-2028 (In $ Million)
Figure 18: North America Immunosuppressant Drugs Market, By Mtor Inhibitors, 2019-2028 (In $ Million)
Figure 19: North America Immunosuppressant Drugs Market, By Others, 2019-2028 (In $ Million)
Figure 20: North America Immunosuppressant Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 21: United States Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 22: Canada Immunosuppressant Drugs Market, 2019-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - IMMUNOSUPPRESSANT DRUGS
TABLE 2: SIDE EFFECTS OF IMMUNOSUPPRESSANT DRUGS
TABLE 3: TOP 15 POSITIVE NET EXPORTS COUNTRIES AND NEGATIVE NET EXPORTS FOR DRUGS & MEDICINES COUNTRIES
TABLE 4: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY CLASS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY CLASS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)